Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name ARGX-110
Trade Name
Synonyms JNJ-74494550|Cusatuzumab
Drug Descriptions

Cusatuzumab (ARGX-110) is a monoclonal antibody that targets CD70, resulting in inhibition of CD70-CD27-mediated signaling and enhanced immune response against CD70-expressing tumor cells (PMID: 28765328, PMID: 24492296, PMID: 32601337).

CAS Registry Number 1864871-20-4
NCIT ID C106116


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
ARGX-110 ARGX-110 0 0
ARGX-110 + Azacitidine ARGX-110 Azacitidine 0 3
ARGX-110 + Azacitidine + Venetoclax ARGX-110 Azacitidine Venetoclax 0 1
ARGX-110 + Decitabine ARGX-110 Decitabine 0 0
ARGX-110 + Venetoclax ARGX-110 Venetoclax 0 1

Additional content available in CKB BOOST